There have been population-based studies that deny there being a cure for the cancer, and others that have claimed there being a cure, but there isn’t. Reports developed around 40 years ago examining a collective excess mortality of nearly 60% among patients with breast cancer after initial treatment of those 15-20 years of age (Langlands et al., 2009). Studies examining direct-cause mortality displayed that the majority, or 66% of the excess mortality noticed breast cancer patients at 16-20 year old follow ups were from breast cancer. A population-based study analyzed the reason for death of 418 deceased breast cancer patients who survived for a minimum of 10 years after diagnosis. The study revealed that 47% of the deaths were from breast cancer and 12% from another cancer, and there was an overall mortality rate of 60 percent at 20 year follow-up mark (Louwman). Despite a normal or elevated life expectancy for patients two decades after diagnosis, the chances of dying from the disease stayed high. A 20 year follow-up implies that patients have had to disease up to that point, which is an extensive amount of time put into localized treatments. What many people assume is that the extensive amount of time spent conducting studies and receiving treatments is simply a method forced by the government and used by medical practitioners to acquire huge amounts of
There have been population-based studies that deny there being a cure for the cancer, and others that have claimed there being a cure, but there isn’t. Reports developed around 40 years ago examining a collective excess mortality of nearly 60% among patients with breast cancer after initial treatment of those 15-20 years of age (Langlands et al., 2009). Studies examining direct-cause mortality displayed that the majority, or 66% of the excess mortality noticed breast cancer patients at 16-20 year old follow ups were from breast cancer. A population-based study analyzed the reason for death of 418 deceased breast cancer patients who survived for a minimum of 10 years after diagnosis. The study revealed that 47% of the deaths were from breast cancer and 12% from another cancer, and there was an overall mortality rate of 60 percent at 20 year follow-up mark (Louwman). Despite a normal or elevated life expectancy for patients two decades after diagnosis, the chances of dying from the disease stayed high. A 20 year follow-up implies that patients have had to disease up to that point, which is an extensive amount of time put into localized treatments. What many people assume is that the extensive amount of time spent conducting studies and receiving treatments is simply a method forced by the government and used by medical practitioners to acquire huge amounts of